

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 5.54585669 |
| 2 | lysine metabolic process (GO:0006553) | 5.54585669 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 5.42699693 |
| 4 | NADH metabolic process (GO:0006734) | 5.16400062 |
| 5 | proline biosynthetic process (GO:0006561) | 5.04852581 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 4.81646343 |
| 7 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.69490955 |
| 8 | 2-oxoglutarate metabolic process (GO:0006103) | 4.67239643 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 4.65959438 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.60162134 |
| 11 | aspartate family amino acid catabolic process (GO:0009068) | 4.52598046 |
| 12 | regulation of translational fidelity (GO:0006450) | 4.50492555 |
| 13 | respiratory electron transport chain (GO:0022904) | 4.37909662 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 4.31380381 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 4.31380381 |
| 16 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.31366027 |
| 17 | oxidative phosphorylation (GO:0006119) | 4.31107711 |
| 18 | carnitine shuttle (GO:0006853) | 4.27878305 |
| 19 | electron transport chain (GO:0022900) | 4.24840809 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.23129940 |
| 21 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.21426029 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.19732592 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 4.19732592 |
| 24 | fatty acid catabolic process (GO:0009062) | 4.17495541 |
| 25 | fatty acid oxidation (GO:0019395) | 4.17064561 |
| 26 | acetyl-CoA metabolic process (GO:0006084) | 4.16099239 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.11247543 |
| 28 | lipid oxidation (GO:0034440) | 4.10823302 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.05614919 |
| 30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.05090305 |
| 31 | ATP synthesis coupled proton transport (GO:0015986) | 4.05090305 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 4.02556626 |
| 33 | oxaloacetate metabolic process (GO:0006107) | 3.98207879 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 3.97197609 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.95918806 |
| 36 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.85554782 |
| 37 | branched-chain amino acid catabolic process (GO:0009083) | 3.85121676 |
| 38 | monocarboxylic acid catabolic process (GO:0072329) | 3.77131035 |
| 39 | apoptotic process involved in morphogenesis (GO:0060561) | 3.71011168 |
| 40 | negative regulation of cell size (GO:0045792) | 3.69945214 |
| 41 | pentose-phosphate shunt (GO:0006098) | 3.69759256 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.69356386 |
| 43 | cysteine metabolic process (GO:0006534) | 3.69104113 |
| 44 | tricarboxylic acid metabolic process (GO:0072350) | 3.68285564 |
| 45 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.67599983 |
| 46 | inner mitochondrial membrane organization (GO:0007007) | 3.67440591 |
| 47 | regulation of sequestering of triglyceride (GO:0010889) | 3.65480846 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.62254589 |
| 49 | L-phenylalanine catabolic process (GO:0006559) | 3.62254589 |
| 50 | carnitine metabolic process (GO:0009437) | 3.61999746 |
| 51 | ketone body metabolic process (GO:1902224) | 3.61909305 |
| 52 | DNA unwinding involved in DNA replication (GO:0006268) | 3.61341046 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.61162718 |
| 54 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.57179618 |
| 55 | succinate metabolic process (GO:0006105) | 3.57015152 |
| 56 | sarcomere organization (GO:0045214) | 3.51563802 |
| 57 | branched-chain amino acid metabolic process (GO:0009081) | 3.51187360 |
| 58 | protein retention in ER lumen (GO:0006621) | 3.50796591 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 3.50294777 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.49704871 |
| 61 | cell-substrate adherens junction assembly (GO:0007045) | 3.48787927 |
| 62 | focal adhesion assembly (GO:0048041) | 3.48787927 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 3.48003180 |
| 64 | regulation of coenzyme metabolic process (GO:0051196) | 3.48003180 |
| 65 | regulation of early endosome to late endosome transport (GO:2000641) | 3.47646471 |
| 66 | protein maturation by protein folding (GO:0022417) | 3.47561387 |
| 67 | ethanol oxidation (GO:0006069) | 3.47278703 |
| 68 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.46646902 |
| 69 | proline metabolic process (GO:0006560) | 3.45787545 |
| 70 | carnitine transport (GO:0015879) | 3.45521989 |
| 71 | amino-acid betaine transport (GO:0015838) | 3.45521989 |
| 72 | biotin metabolic process (GO:0006768) | 3.44703486 |
| 73 | glucose catabolic process (GO:0006007) | 3.43198277 |
| 74 | galactose catabolic process (GO:0019388) | 3.42560201 |
| 75 | sulfur amino acid catabolic process (GO:0000098) | 3.42197801 |
| 76 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.41678321 |
| 77 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.39188663 |
| 78 | adherens junction assembly (GO:0034333) | 3.36980191 |
| 79 | ncRNA 3-end processing (GO:0043628) | 3.36400556 |
| 80 | carnitine transmembrane transport (GO:1902603) | 3.36220837 |
| 81 | GDP-mannose metabolic process (GO:0019673) | 3.35187160 |
| 82 | activation of Rac GTPase activity (GO:0032863) | 3.34798825 |
| 83 | ubiquinone biosynthetic process (GO:0006744) | 3.31920027 |
| 84 | quinone biosynthetic process (GO:1901663) | 3.31920027 |
| 85 | alpha-linolenic acid metabolic process (GO:0036109) | 3.29675195 |
| 86 | NAD metabolic process (GO:0019674) | 3.28251099 |
| 87 | positive regulation of fatty acid oxidation (GO:0046321) | 3.28096205 |
| 88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.27825236 |
| 89 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.27546144 |
| 90 | protein complex localization (GO:0031503) | 3.27298290 |
| 91 | mitochondrial fusion (GO:0008053) | 3.26322898 |
| 92 | organic acid catabolic process (GO:0016054) | 3.24110215 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.24110215 |
| 94 | aromatic amino acid family catabolic process (GO:0009074) | 3.22098338 |
| 95 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.20212695 |
| 96 | formation of translation preinitiation complex (GO:0001731) | 3.19449673 |
| 97 | glucose 6-phosphate metabolic process (GO:0051156) | 3.18959292 |
| 98 | histone arginine methylation (GO:0034969) | 3.18244391 |
| 99 | protein localization to endosome (GO:0036010) | 3.16379811 |
| 100 | NADPH regeneration (GO:0006740) | 3.15382112 |
| 101 | dicarboxylic acid catabolic process (GO:0043649) | 3.15330031 |
| 102 | quaternary ammonium group transport (GO:0015697) | 3.14495324 |
| 103 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.13801166 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.12522695 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12030475 |
| 106 | alpha-amino acid catabolic process (GO:1901606) | 3.11713991 |
| 107 | maternal placenta development (GO:0001893) | 3.11533475 |
| 108 | mitotic chromosome condensation (GO:0007076) | 3.10716396 |
| 109 | cellular amino acid catabolic process (GO:0009063) | 3.09797773 |
| 110 | glycine metabolic process (GO:0006544) | 3.08740144 |
| 111 | regulation of triglyceride catabolic process (GO:0010896) | 3.07617190 |
| 112 | regulation of mitochondrial translation (GO:0070129) | 3.03642497 |
| 113 | coenzyme A biosynthetic process (GO:0015937) | 3.03131268 |
| 114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02498295 |
| 115 | coenzyme catabolic process (GO:0009109) | 3.01981292 |
| 116 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.01368585 |
| 117 | serine family amino acid metabolic process (GO:0009069) | 3.01087925 |
| 118 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.98943939 |
| 119 | tryptophan catabolic process (GO:0006569) | 2.98646411 |
| 120 | indole-containing compound catabolic process (GO:0042436) | 2.98646411 |
| 121 | indolalkylamine catabolic process (GO:0046218) | 2.98646411 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97936935 |
| 123 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96784223 |
| 124 | peptidyl-arginine methylation (GO:0018216) | 2.94674257 |
| 125 | peptidyl-arginine N-methylation (GO:0035246) | 2.94674257 |
| 126 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.93451392 |
| 127 | ubiquinone metabolic process (GO:0006743) | 2.92864562 |
| 128 | drug transmembrane transport (GO:0006855) | 2.92670962 |
| 129 | gluconeogenesis (GO:0006094) | 2.90980513 |
| 130 | viral transcription (GO:0019083) | 2.90870734 |
| 131 | coenzyme A metabolic process (GO:0015936) | 2.90332077 |
| 132 | dicarboxylic acid metabolic process (GO:0043648) | 2.90329714 |
| 133 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.89600776 |
| 134 | valine metabolic process (GO:0006573) | 2.87966482 |
| 135 | aldehyde catabolic process (GO:0046185) | 2.87264713 |
| 136 | cardiac muscle contraction (GO:0060048) | 2.87258360 |
| 137 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.86863095 |
| 138 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.85624741 |
| 139 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.85602288 |
| 140 | hexose biosynthetic process (GO:0019319) | 2.81532012 |
| 141 | cellular protein complex localization (GO:0034629) | 2.81335664 |
| 142 | glutamate metabolic process (GO:0006536) | 2.81334416 |
| 143 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.81230822 |
| 144 | regulation of translational termination (GO:0006449) | 2.78976820 |
| 145 | ethanol metabolic process (GO:0006067) | 2.78052002 |
| 146 | ATP biosynthetic process (GO:0006754) | 2.77629946 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77257591 |
| 148 | monosaccharide biosynthetic process (GO:0046364) | 2.76800943 |
| 149 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.76684962 |
| 150 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.75955241 |
| 151 | urea cycle (GO:0000050) | 2.75280001 |
| 152 | pinocytosis (GO:0006907) | 2.72902235 |
| 153 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.70862630 |
| 154 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.64754148 |
| 155 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.64754073 |
| 156 | nuclear envelope reassembly (GO:0031468) | 2.63932566 |
| 157 | mitotic nuclear envelope reassembly (GO:0007084) | 2.63932566 |
| 158 | pentose metabolic process (GO:0019321) | 2.63342635 |
| 159 | barbed-end actin filament capping (GO:0051016) | 2.59989797 |
| 160 | rRNA transcription (GO:0009303) | 2.59873099 |
| 161 | modulation by symbiont of host cellular process (GO:0044068) | 2.59140829 |
| 162 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.59095912 |
| 163 | modulation by virus of host process (GO:0019054) | 2.58910241 |
| 164 | cell-substrate junction assembly (GO:0007044) | 2.58307467 |
| 165 | creatine metabolic process (GO:0006600) | 2.58110327 |
| 166 | glycolytic process (GO:0006096) | 2.57471217 |
| 167 | translational elongation (GO:0006414) | 2.56986975 |
| 168 | translational termination (GO:0006415) | 2.56915590 |
| 169 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.55263468 |
| 170 | folic acid metabolic process (GO:0046655) | 2.54473927 |
| 171 | heterochromatin organization (GO:0070828) | 2.54302704 |
| 172 | UV protection (GO:0009650) | 2.53089491 |
| 173 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.52427107 |
| 174 | DNA strand elongation (GO:0022616) | 2.51275262 |
| 175 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.49157486 |
| 176 | pyrimidine-containing compound salvage (GO:0008655) | 2.48876865 |
| 177 | pyrimidine nucleoside salvage (GO:0043097) | 2.48876865 |
| 178 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.47956571 |
| 179 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.47720712 |
| 180 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47252952 |
| 181 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.46427486 |
| 182 | desmosome organization (GO:0002934) | 2.46088344 |
| 183 | adenine nucleotide transport (GO:0051503) | 2.45058564 |
| 184 | DNA replication initiation (GO:0006270) | 2.43599884 |
| 185 | regulation of cholesterol homeostasis (GO:2000188) | 2.43291287 |
| 186 | ribosome biogenesis (GO:0042254) | 2.42537592 |
| 187 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.42528779 |
| 188 | positive regulation of nuclease activity (GO:0032075) | 2.42514156 |
| 189 | modulation by virus of host morphology or physiology (GO:0019048) | 2.41731216 |
| 190 | RNA stabilization (GO:0043489) | 2.41272063 |
| 191 | mRNA stabilization (GO:0048255) | 2.41272063 |
| 192 | urea metabolic process (GO:0019627) | 2.39782753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.59714392 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.31455475 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27265667 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.07922980 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.98661675 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.56718134 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.26793694 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25669793 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.04577078 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76461339 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.59208307 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55774614 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.48279611 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.44979630 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37948588 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30960331 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20779638 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06110464 |
| 19 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93008866 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90594737 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89849851 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86014563 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82577666 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80899686 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77091573 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74455981 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73463912 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72082670 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71447862 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67269716 |
| 31 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.65792031 |
| 32 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65738981 |
| 33 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.64113023 |
| 34 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63213042 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61712660 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56948349 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56929095 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55680432 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55587166 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.54600359 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49626589 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49353647 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48173495 |
| 44 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47159864 |
| 45 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.45946709 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45885751 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43712200 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.42836693 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42776203 |
| 50 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.42060381 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39399680 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37756624 |
| 53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36286669 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34511827 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33840477 |
| 56 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32824119 |
| 57 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.32297548 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31289638 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30352718 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30347215 |
| 61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29263143 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.25848470 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25034536 |
| 64 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23095045 |
| 65 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22982458 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22107469 |
| 67 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21811818 |
| 68 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21334580 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20886476 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20803164 |
| 71 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20772462 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20145576 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19888237 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19241230 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18430194 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13592250 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13479586 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13425341 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13304903 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12974060 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.12811302 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12355694 |
| 83 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.12031047 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11490122 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11447298 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10888130 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10299921 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09498619 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09156592 |
| 90 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.08862963 |
| 91 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08642950 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08241336 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08117886 |
| 94 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08001528 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 1.07961622 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07702707 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07575562 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.07369140 |
| 99 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06744513 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04174927 |
| 101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03833431 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03564752 |
| 103 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03435892 |
| 104 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02443738 |
| 105 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01560479 |
| 106 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99975798 |
| 107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99440588 |
| 108 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99003801 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97766400 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96344778 |
| 111 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95881429 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95821860 |
| 113 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95682825 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.95323510 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94639057 |
| 116 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94276888 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94220411 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94220411 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93952221 |
| 120 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93059057 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92370842 |
| 122 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92302930 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91327092 |
| 124 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89524930 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88944308 |
| 126 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88549434 |
| 127 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88263521 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88154628 |
| 129 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.87892404 |
| 130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87438661 |
| 131 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85558813 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84774671 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84549702 |
| 134 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.83918004 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83116288 |
| 136 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82478410 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81361604 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81100037 |
| 139 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.80786590 |
| 140 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80713163 |
| 141 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.80553715 |
| 142 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80000393 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79900264 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79203592 |
| 145 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.76968115 |
| 146 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76934238 |
| 147 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76748226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.61247057 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.43839389 |
| 3 | MP0005360_urolithiasis | 4.38191577 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.18278821 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.34300794 |
| 6 | MP0005365_abnormal_bile_salt | 3.31332318 |
| 7 | MP0003195_calcinosis | 3.28769004 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.27348775 |
| 9 | MP0000751_myopathy | 3.21883013 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.84933029 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.75942298 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.74757038 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.73641583 |
| 14 | MP0005330_cardiomyopathy | 2.71616969 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52809012 |
| 16 | MP0000749_muscle_degeneration | 2.51501172 |
| 17 | MP0005332_abnormal_amino_acid | 2.41221833 |
| 18 | MP0004130_abnormal_muscle_cell | 2.40363412 |
| 19 | MP0005670_abnormal_white_adipose | 2.39308693 |
| 20 | MP0004858_abnormal_nervous_system | 2.38989448 |
| 21 | MP0008260_abnormal_autophagy | 2.34389438 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.33074302 |
| 23 | MP0001849_ear_inflammation | 2.28265676 |
| 24 | MP0005666_abnormal_adipose_tissue | 2.19389773 |
| 25 | MP0005076_abnormal_cell_differentiation | 2.14093132 |
| 26 | MP0009840_abnormal_foam_cell | 2.13486864 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.04722922 |
| 28 | MP0002796_impaired_skin_barrier | 2.01565059 |
| 29 | MP0000678_abnormal_parathyroid_gland | 2.00680181 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.99862233 |
| 31 | MP0002269_muscular_atrophy | 1.94325172 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.92482655 |
| 33 | MP0004510_myositis | 1.92108924 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.89481935 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.88854161 |
| 36 | MP0005083_abnormal_biliary_tract | 1.85176914 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.84883853 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.82685161 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.81438610 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75601070 |
| 41 | MP0005501_abnormal_skin_physiology | 1.73469310 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.69673541 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.67736040 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.66958196 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.66640134 |
| 46 | MP0001730_embryonic_growth_arrest | 1.64451644 |
| 47 | MP0000747_muscle_weakness | 1.63001216 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.62516947 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.60846960 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.60410437 |
| 51 | MP0003252_abnormal_bile_duct | 1.58709211 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.58158449 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.55583050 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.55277125 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.54798124 |
| 56 | MP0009278_abnormal_bone_marrow | 1.53378599 |
| 57 | MP0002089_abnormal_postnatal_growth/wei | 1.52844641 |
| 58 | MP0003186_abnormal_redox_activity | 1.52513225 |
| 59 | MP0004957_abnormal_blastocyst_morpholog | 1.52165638 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49990391 |
| 61 | MP0005451_abnormal_body_composition | 1.49873434 |
| 62 | MP0000733_abnormal_muscle_development | 1.49414270 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.44117309 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.43975480 |
| 65 | MP0001873_stomach_inflammation | 1.43621609 |
| 66 | MP0004484_altered_response_of | 1.42665614 |
| 67 | MP0005385_cardiovascular_system_phenoty | 1.42266328 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 1.42266328 |
| 69 | MP0001661_extended_life_span | 1.38344957 |
| 70 | MP0000537_abnormal_urethra_morphology | 1.37248025 |
| 71 | MP0001764_abnormal_homeostasis | 1.34871859 |
| 72 | MP0004043_abnormal_pH_regulation | 1.34564062 |
| 73 | MP0009672_abnormal_birth_weight | 1.34185307 |
| 74 | MP0003123_paternal_imprinting | 1.33709012 |
| 75 | MP0002249_abnormal_larynx_morphology | 1.32980838 |
| 76 | MP0010030_abnormal_orbit_morphology | 1.32843210 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.30634016 |
| 78 | MP0005535_abnormal_body_temperature | 1.29814159 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.29465221 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.29124642 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.25861335 |
| 82 | MP0000490_abnormal_crypts_of | 1.23707851 |
| 83 | MP0003329_amyloid_beta_deposits | 1.23597855 |
| 84 | MP0002971_abnormal_brown_adipose | 1.22758775 |
| 85 | MP0000759_abnormal_skeletal_muscle | 1.21887034 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 1.20694730 |
| 87 | MP0003879_abnormal_hair_cell | 1.20531190 |
| 88 | MP0003077_abnormal_cell_cycle | 1.19814964 |
| 89 | MP0000858_altered_metastatic_potential | 1.19589597 |
| 90 | MP0000609_abnormal_liver_physiology | 1.19236763 |
| 91 | MP0000350_abnormal_cell_proliferation | 1.15603583 |
| 92 | MP0010630_abnormal_cardiac_muscle | 1.11094249 |
| 93 | MP0004947_skin_inflammation | 1.10404996 |
| 94 | MP0006138_congestive_heart_failure | 1.10220713 |
| 95 | MP0010094_abnormal_chromosome_stability | 1.10094618 |
| 96 | MP0002080_prenatal_lethality | 1.09802613 |
| 97 | MP0002822_catalepsy | 1.09201431 |
| 98 | MP0008932_abnormal_embryonic_tissue | 1.08651795 |
| 99 | MP0005623_abnormal_meninges_morphology | 1.08384960 |
| 100 | MP0005369_muscle_phenotype | 1.06949663 |
| 101 | MP0002909_abnormal_adrenal_gland | 1.06285456 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 1.05540255 |
| 103 | MP0005257_abnormal_intraocular_pressure | 1.03856190 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 1.03744864 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 1.00203926 |
| 106 | MP0005165_increased_susceptibility_to | 0.99700133 |
| 107 | MP0004859_abnormal_synaptic_plasticity | 0.98550151 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.98508224 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.98206933 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.98046060 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.97319209 |
| 112 | MP0005266_abnormal_metabolism | 0.96144172 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.91386785 |
| 114 | MP0004085_abnormal_heartbeat | 0.91255823 |
| 115 | MP0000313_abnormal_cell_death | 0.91116581 |
| 116 | MP0005621_abnormal_cell_physiology | 0.90777038 |
| 117 | MP0005334_abnormal_fat_pad | 0.89147197 |
| 118 | MP0009379_abnormal_foot_pigmentation | 0.88696067 |
| 119 | MP0002060_abnormal_skin_morphology | 0.88281781 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.87474992 |
| 121 | MP0005409_darkened_coat_color | 0.87318426 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.86974894 |
| 123 | MP0004233_abnormal_muscle_weight | 0.86360486 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.85886750 |
| 125 | MP0004808_abnormal_hematopoietic_stem | 0.83965234 |
| 126 | MP0008438_abnormal_cutaneous_collagen | 0.83352243 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.82664926 |
| 128 | MP0003984_embryonic_growth_retardation | 0.82284843 |
| 129 | MP0005380_embryogenesis_phenotype | 0.81852266 |
| 130 | MP0001672_abnormal_embryogenesis/_devel | 0.81852266 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.80532823 |
| 132 | MP0003075_altered_response_to | 0.80158551 |
| 133 | MP0000579_abnormal_nail_morphology | 0.79957704 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.79724293 |
| 135 | MP0009931_abnormal_skin_appearance | 0.78896912 |
| 136 | MP0004147_increased_porphyrin_level | 0.78607642 |
| 137 | MP0000467_abnormal_esophagus_morphology | 0.77678289 |
| 138 | MP0000762_abnormal_tongue_morphology | 0.77237845 |
| 139 | MP0000604_amyloidosis | 0.75500254 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.75279052 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.74884344 |
| 142 | MP0005384_cellular_phenotype | 0.74340023 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.74115530 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.73524378 |
| 145 | MP0002088_abnormal_embryonic_growth/wei | 0.72984944 |
| 146 | MP0001756_abnormal_urination | 0.71607496 |
| 147 | MP0003011_delayed_dark_adaptation | 0.70667067 |
| 148 | MP0000462_abnormal_digestive_system | 0.69103146 |
| 149 | MP0002086_abnormal_extraembryonic_tissu | 0.68676087 |
| 150 | MP0000343_altered_response_to | 0.68528488 |
| 151 | MP0008874_decreased_physiological_sensi | 0.68058231 |
| 152 | MP0000477_abnormal_intestine_morphology | 0.67627586 |
| 153 | MP0004142_abnormal_muscle_tone | 0.67097433 |
| 154 | MP0001697_abnormal_embryo_size | 0.66927420 |
| 155 | MP0003828_pulmonary_edema | 0.65839086 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.64582111 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.64454044 |
| 158 | MP0005448_abnormal_energy_balance | 0.64324666 |
| 159 | MP0002970_abnormal_white_adipose | 0.60326061 |
| 160 | MP0003953_abnormal_hormone_level | 0.59473441 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.58375809 |
| 162 | MP0002876_abnormal_thyroid_physiology | 0.57426020 |
| 163 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56355803 |
| 164 | MP0000598_abnormal_liver_morphology | 0.55939904 |
| 165 | MP0005452_abnormal_adipose_tissue | 0.54541742 |
| 166 | MP0000003_abnormal_adipose_tissue | 0.53042077 |
| 167 | MP0000358_abnormal_cell_content/ | 0.50856298 |
| 168 | MP0003878_abnormal_ear_physiology | 0.49047108 |
| 169 | MP0005377_hearing/vestibular/ear_phenot | 0.49047108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.40896885 |
| 2 | Hyperglycinuria (HP:0003108) | 4.19623619 |
| 3 | Hepatic necrosis (HP:0002605) | 4.18206317 |
| 4 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01102088 |
| 5 | Hyperammonemia (HP:0001987) | 3.95162271 |
| 6 | Ketosis (HP:0001946) | 3.88307320 |
| 7 | Ketoacidosis (HP:0001993) | 3.83886545 |
| 8 | Myoglobinuria (HP:0002913) | 3.81682038 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.79005177 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 3.73660524 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73591015 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.73591015 |
| 13 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.72677503 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 3.72677503 |
| 15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.72313980 |
| 16 | Acute encephalopathy (HP:0006846) | 3.65449937 |
| 17 | Abnormality of alanine metabolism (HP:0010916) | 3.63214475 |
| 18 | Hyperalaninemia (HP:0003348) | 3.63214475 |
| 19 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.63214475 |
| 20 | Hyperacusis (HP:0010780) | 3.59831492 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.57182770 |
| 22 | Cerebral edema (HP:0002181) | 3.54066849 |
| 23 | Hyperglycinemia (HP:0002154) | 3.53350067 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 3.52082852 |
| 25 | Myopathic facies (HP:0002058) | 3.49743051 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.44496083 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 3.40912963 |
| 28 | Achilles tendon contracture (HP:0001771) | 3.38886041 |
| 29 | Exercise-induced myalgia (HP:0003738) | 3.36950882 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.28663768 |
| 31 | Increased connective tissue (HP:0009025) | 3.27833785 |
| 32 | Lactic acidosis (HP:0003128) | 3.27433335 |
| 33 | Abnormality of glycolysis (HP:0004366) | 3.26992186 |
| 34 | Increased serum pyruvate (HP:0003542) | 3.26992186 |
| 35 | Increased muscle lipid content (HP:0009058) | 3.24645305 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22868476 |
| 37 | Mitochondrial inheritance (HP:0001427) | 3.20490666 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.20319097 |
| 39 | Lethargy (HP:0001254) | 3.14564334 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09480519 |
| 41 | Palpitations (HP:0001962) | 3.08426461 |
| 42 | Increased CSF lactate (HP:0002490) | 3.05835128 |
| 43 | Gout (HP:0001997) | 3.01019603 |
| 44 | Nausea (HP:0002018) | 2.99242053 |
| 45 | Metabolic acidosis (HP:0001942) | 2.94209122 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.88558091 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.88558091 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.85911568 |
| 49 | Exercise-induced muscle cramps (HP:0003710) | 2.84912103 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.78994528 |
| 51 | Xanthomatosis (HP:0000991) | 2.78837207 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.73633423 |
| 53 | Increased serum lactate (HP:0002151) | 2.72668912 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.71491713 |
| 55 | Stridor (HP:0010307) | 2.71132478 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 2.70432706 |
| 57 | Cholecystitis (HP:0001082) | 2.68655893 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.68655893 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.68311177 |
| 60 | Progressive macrocephaly (HP:0004481) | 2.64989774 |
| 61 | Muscle fiber inclusion bodies (HP:0100299) | 2.62811316 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.62263923 |
| 63 | Calf muscle hypertrophy (HP:0008981) | 2.61913898 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.61193675 |
| 65 | Vomiting (HP:0002013) | 2.59640712 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.59129092 |
| 67 | Nemaline bodies (HP:0003798) | 2.59091249 |
| 68 | Hypoalphalipoproteinemia (HP:0003233) | 2.58455798 |
| 69 | Round ear (HP:0100830) | 2.57508058 |
| 70 | Intrahepatic cholestasis (HP:0001406) | 2.57384255 |
| 71 | Atrioventricular block (HP:0001678) | 2.57093208 |
| 72 | CNS demyelination (HP:0007305) | 2.54895748 |
| 73 | Insomnia (HP:0100785) | 2.54201309 |
| 74 | Lower limb amyotrophy (HP:0007210) | 2.52618544 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.50744596 |
| 76 | Syncope (HP:0001279) | 2.50733824 |
| 77 | Respiratory failure (HP:0002878) | 2.49441643 |
| 78 | Trismus (HP:0000211) | 2.46989283 |
| 79 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.44299810 |
| 80 | Lipoatrophy (HP:0100578) | 2.42789057 |
| 81 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41185537 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.40401477 |
| 83 | Dilated cardiomyopathy (HP:0001644) | 2.40267199 |
| 84 | Distal upper limb amyotrophy (HP:0007149) | 2.39261841 |
| 85 | Upper limb amyotrophy (HP:0009129) | 2.39261841 |
| 86 | Type 1 muscle fiber predominance (HP:0003803) | 2.39120472 |
| 87 | Bulbar palsy (HP:0001283) | 2.38826072 |
| 88 | Heart block (HP:0012722) | 2.37902100 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.37817328 |
| 90 | Increased purine levels (HP:0004368) | 2.37413347 |
| 91 | Hyperuricemia (HP:0002149) | 2.37413347 |
| 92 | Atrial fibrillation (HP:0005110) | 2.35391272 |
| 93 | Methylmalonic aciduria (HP:0012120) | 2.35020752 |
| 94 | Bundle branch block (HP:0011710) | 2.34724854 |
| 95 | Abnormal atrioventricular conduction (HP:0005150) | 2.34512322 |
| 96 | Supraventricular tachycardia (HP:0004755) | 2.32172547 |
| 97 | Abnormality of the calf musculature (HP:0001430) | 2.31199912 |
| 98 | Hypobetalipoproteinemia (HP:0003563) | 2.30972793 |
| 99 | Supraventricular arrhythmia (HP:0005115) | 2.30689999 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.30500354 |
| 101 | Primary atrial arrhythmia (HP:0001692) | 2.30133122 |
| 102 | Exercise intolerance (HP:0003546) | 2.29792321 |
| 103 | Reticulocytosis (HP:0001923) | 2.26019922 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 2.24391670 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24109944 |
| 106 | Progressive muscle weakness (HP:0003323) | 2.23425339 |
| 107 | Proximal tubulopathy (HP:0000114) | 2.23191796 |
| 108 | Microvesicular hepatic steatosis (HP:0001414) | 2.23110243 |
| 109 | Ulnar bowing (HP:0003031) | 2.22829959 |
| 110 | Broad face (HP:0000283) | 2.19607961 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 2.16330292 |
| 112 | Oligomenorrhea (HP:0000876) | 2.15395884 |
| 113 | Generalized amyotrophy (HP:0003700) | 2.12292786 |
| 114 | Ventricular arrhythmia (HP:0004308) | 2.11545347 |
| 115 | Athetosis (HP:0002305) | 2.11450059 |
| 116 | Hyperlipoproteinemia (HP:0010980) | 2.11297913 |
| 117 | Deep venous thrombosis (HP:0002625) | 2.10911374 |
| 118 | Lipid accumulation in hepatocytes (HP:0006561) | 2.10777011 |
| 119 | Conjunctival hamartoma (HP:0100780) | 2.09552246 |
| 120 | Glycosuria (HP:0003076) | 2.08765373 |
| 121 | Abnormality of urine glucose concentration (HP:0011016) | 2.08765373 |
| 122 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07614241 |
| 123 | Muscle stiffness (HP:0003552) | 2.06152879 |
| 124 | Late onset (HP:0003584) | 2.06031491 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04952141 |
| 126 | EMG: myopathic abnormalities (HP:0003458) | 2.03827460 |
| 127 | Prolonged QT interval (HP:0001657) | 2.03736236 |
| 128 | Premature rupture of membranes (HP:0001788) | 2.03684492 |
| 129 | Hyporeflexia of lower limbs (HP:0002600) | 2.03283261 |
| 130 | Difficulty climbing stairs (HP:0003551) | 2.01171986 |
| 131 | Pheochromocytoma (HP:0002666) | 2.00544869 |
| 132 | Progressive external ophthalmoplegia (HP:0000590) | 2.00331967 |
| 133 | Flat acetabular roof (HP:0003180) | 1.99925938 |
| 134 | Testicular atrophy (HP:0000029) | 1.97730418 |
| 135 | Long palpebral fissure (HP:0000637) | 1.92667089 |
| 136 | Broad distal phalanx of finger (HP:0009836) | 1.91925744 |
| 137 | Dysmetric saccades (HP:0000641) | 1.91911208 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.91692284 |
| 139 | Abnormality of the tricuspid valve (HP:0001702) | 1.91255438 |
| 140 | Truncus arteriosus (HP:0001660) | 1.90738123 |
| 141 | Fragile skin (HP:0001030) | 1.89100947 |
| 142 | Foot dorsiflexor weakness (HP:0009027) | 1.87957048 |
| 143 | Hyperthyroidism (HP:0000836) | 1.87888961 |
| 144 | Diaphragmatic weakness (HP:0009113) | 1.87769289 |
| 145 | Protrusio acetabuli (HP:0003179) | 1.83978105 |
| 146 | Abnormality of reticulocytes (HP:0004312) | 1.83754829 |
| 147 | Selective tooth agenesis (HP:0001592) | 1.81608263 |
| 148 | Neck muscle weakness (HP:0000467) | 1.81599971 |
| 149 | J-shaped sella turcica (HP:0002680) | 1.81441232 |
| 150 | Elbow flexion contracture (HP:0002987) | 1.81366110 |
| 151 | Cholelithiasis (HP:0001081) | 1.80907493 |
| 152 | Multiple enchondromatosis (HP:0005701) | 1.80398613 |
| 153 | Hypokinesia (HP:0002375) | 1.78567827 |
| 154 | Spinal rigidity (HP:0003306) | 1.78496825 |
| 155 | Cerebral aneurysm (HP:0004944) | 1.78244413 |
| 156 | Hemorrhage of the eye (HP:0011885) | 1.77687125 |
| 157 | Metaphyseal cupping (HP:0003021) | 1.76205345 |
| 158 | Cellulitis (HP:0100658) | 1.73906517 |
| 159 | Back pain (HP:0003418) | 1.73499013 |
| 160 | Overriding aorta (HP:0002623) | 1.73491719 |
| 161 | Axonal loss (HP:0003447) | 1.72710490 |
| 162 | Abnormality of the umbilical cord (HP:0010881) | 1.72471889 |
| 163 | Premature skin wrinkling (HP:0100678) | 1.72449730 |
| 164 | Rough bone trabeculation (HP:0100670) | 1.70333168 |
| 165 | Colitis (HP:0002583) | 1.69091293 |
| 166 | Abnormality of the foot musculature (HP:0001436) | 1.67060425 |
| 167 | Abnormality of the thoracic spine (HP:0100711) | 1.65920711 |
| 168 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.65347900 |
| 169 | Patellar dislocation (HP:0002999) | 1.62496480 |
| 170 | Short nail (HP:0001799) | 1.62438644 |
| 171 | Obstructive sleep apnea (HP:0002870) | 1.62362110 |
| 172 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62232014 |
| 173 | Easy fatigability (HP:0003388) | 1.61919471 |
| 174 | Growth hormone excess (HP:0000845) | 1.61777581 |
| 175 | Polygenic inheritance (HP:0010982) | 1.61773483 |
| 176 | Thin bony cortex (HP:0002753) | 1.60685854 |
| 177 | Pointed chin (HP:0000307) | 1.60050392 |
| 178 | Elfin facies (HP:0004428) | 1.59681225 |
| 179 | Hypertensive crisis (HP:0100735) | 1.56528864 |
| 180 | Spinal cord compression (HP:0002176) | 1.55232347 |
| 181 | Hand muscle atrophy (HP:0009130) | 1.55151146 |
| 182 | Cupped ribs (HP:0000887) | 1.54611811 |
| 183 | Biconcave vertebral bodies (HP:0004586) | 1.53389318 |
| 184 | Ankle clonus (HP:0011448) | 1.53333680 |
| 185 | Hypercalcemia (HP:0003072) | 1.52892312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.19575303 |
| 2 | TRIB3 | 4.21039379 |
| 3 | SMG1 | 3.80751722 |
| 4 | IRAK3 | 3.14147487 |
| 5 | PHKG1 | 3.05627358 |
| 6 | PHKG2 | 3.05627358 |
| 7 | PKN2 | 2.91044271 |
| 8 | NME2 | 2.87750670 |
| 9 | MAPKAPK3 | 2.82137697 |
| 10 | TTN | 2.75768735 |
| 11 | PRPF4B | 2.63300688 |
| 12 | LMTK2 | 2.63008834 |
| 13 | EEF2K | 2.62366679 |
| 14 | NEK1 | 2.58779298 |
| 15 | ICK | 2.40192518 |
| 16 | PDK4 | 2.33407381 |
| 17 | PDK3 | 2.33407381 |
| 18 | TLK1 | 2.33117050 |
| 19 | OBSCN | 2.23039820 |
| 20 | PINK1 | 2.22172895 |
| 21 | MAP3K11 | 2.12777184 |
| 22 | MYLK | 1.90370684 |
| 23 | NME1 | 1.85075543 |
| 24 | TESK2 | 1.81197436 |
| 25 | TESK1 | 1.68318345 |
| 26 | MAP2K4 | 1.64493178 |
| 27 | EPHA4 | 1.63730607 |
| 28 | MAP3K10 | 1.61659660 |
| 29 | DAPK3 | 1.57267725 |
| 30 | MUSK | 1.49069986 |
| 31 | ARAF | 1.45545889 |
| 32 | MAPK12 | 1.41592779 |
| 33 | TAOK2 | 1.39836863 |
| 34 | MAP3K9 | 1.36258737 |
| 35 | CDK12 | 1.34929729 |
| 36 | WNK4 | 1.30475340 |
| 37 | VRK2 | 1.29788728 |
| 38 | ABL2 | 1.29358209 |
| 39 | MAP3K6 | 1.28753206 |
| 40 | RIPK1 | 1.28610431 |
| 41 | PRKD3 | 1.26677501 |
| 42 | EPHA2 | 1.26675669 |
| 43 | PAK4 | 1.26142372 |
| 44 | RPS6KB2 | 1.24436938 |
| 45 | ILK | 1.21218756 |
| 46 | PDK2 | 1.19624528 |
| 47 | AKT2 | 1.15339377 |
| 48 | DAPK1 | 1.10970111 |
| 49 | MAP3K5 | 1.09215505 |
| 50 | BUB1 | 1.07808249 |
| 51 | MST1R | 1.06762141 |
| 52 | MAPK11 | 1.03944042 |
| 53 | PIM2 | 1.03582819 |
| 54 | IRAK2 | 1.01957202 |
| 55 | SCYL2 | 1.01230846 |
| 56 | MINK1 | 0.96261949 |
| 57 | MAP3K8 | 0.94394083 |
| 58 | PTK6 | 0.91842094 |
| 59 | MAP3K13 | 0.91090344 |
| 60 | MAP3K12 | 0.90425255 |
| 61 | MTOR | 0.89514189 |
| 62 | DMPK | 0.88899241 |
| 63 | LATS2 | 0.85678045 |
| 64 | EIF2AK1 | 0.83104873 |
| 65 | CAMK2D | 0.82078806 |
| 66 | MARK1 | 0.81203146 |
| 67 | CAMK2G | 0.80375914 |
| 68 | STK38L | 0.77609914 |
| 69 | PTK2 | 0.77389375 |
| 70 | MAP2K7 | 0.75939657 |
| 71 | CDK7 | 0.74192679 |
| 72 | NEK9 | 0.71044072 |
| 73 | BMX | 0.70887924 |
| 74 | MAP2K6 | 0.70773460 |
| 75 | EPHB2 | 0.70541805 |
| 76 | PRKAA1 | 0.69868008 |
| 77 | MAP3K4 | 0.69186161 |
| 78 | DAPK2 | 0.69016077 |
| 79 | MAP2K2 | 0.68983150 |
| 80 | BRAF | 0.67575725 |
| 81 | MAP2K1 | 0.66532625 |
| 82 | MAP3K7 | 0.63557230 |
| 83 | MET | 0.61478205 |
| 84 | PRKAA2 | 0.59952563 |
| 85 | KDR | 0.59915533 |
| 86 | PRKD2 | 0.58397827 |
| 87 | FGFR4 | 0.58099778 |
| 88 | CDK4 | 0.57814484 |
| 89 | ERN1 | 0.57569853 |
| 90 | PRKCI | 0.57302196 |
| 91 | MAP3K3 | 0.57047009 |
| 92 | FLT3 | 0.56367489 |
| 93 | MARK2 | 0.56211698 |
| 94 | STK38 | 0.54830698 |
| 95 | PDPK1 | 0.54531334 |
| 96 | RPS6KA2 | 0.54048141 |
| 97 | MAP4K1 | 0.53720645 |
| 98 | SIK1 | 0.53621194 |
| 99 | NTRK1 | 0.52782789 |
| 100 | IRAK4 | 0.51698380 |
| 101 | CDK8 | 0.50700776 |
| 102 | PRKACG | 0.50309877 |
| 103 | UHMK1 | 0.49918898 |
| 104 | RAF1 | 0.48714192 |
| 105 | PBK | 0.48652402 |
| 106 | AURKA | 0.47813856 |
| 107 | RPS6KC1 | 0.47384148 |
| 108 | RPS6KL1 | 0.47384148 |
| 109 | MAPK4 | 0.47031146 |
| 110 | STK24 | 0.45797048 |
| 111 | CAMKK1 | 0.45453491 |
| 112 | PRKCZ | 0.44639704 |
| 113 | CAMK2A | 0.43488587 |
| 114 | WNK3 | 0.42646055 |
| 115 | MAP2K3 | 0.41837770 |
| 116 | PRKD1 | 0.41572251 |
| 117 | PRKG2 | 0.41478431 |
| 118 | TAOK1 | 0.41149677 |
| 119 | PRKCG | 0.40676275 |
| 120 | PDK1 | 0.40316493 |
| 121 | CDC7 | 0.40188962 |
| 122 | KSR2 | 0.39771391 |
| 123 | ROCK1 | 0.39383000 |
| 124 | RPS6KA4 | 0.38365617 |
| 125 | PAK3 | 0.37531151 |
| 126 | BRSK1 | 0.37373215 |
| 127 | CDK11A | 0.37337339 |
| 128 | PRKACA | 0.37336317 |
| 129 | PAK1 | 0.37178520 |
| 130 | PAK2 | 0.36860914 |
| 131 | ALK | 0.36857054 |
| 132 | CDK5 | 0.35816130 |
| 133 | STK4 | 0.35349058 |
| 134 | TBK1 | 0.35239754 |
| 135 | CHEK2 | 0.34874427 |
| 136 | SIK2 | 0.33521380 |
| 137 | CAMK1 | 0.33174438 |
| 138 | LIMK1 | 0.32770402 |
| 139 | PAK6 | 0.32460748 |
| 140 | CAMK2B | 0.31764886 |
| 141 | PDGFRA | 0.31712355 |
| 142 | DYRK2 | 0.31227599 |
| 143 | STK11 | 0.30497346 |
| 144 | MAP3K1 | 0.28316985 |
| 145 | LRRK2 | 0.27036473 |
| 146 | CDC42BPA | 0.26729617 |
| 147 | FER | 0.26409461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.03748924 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.80026472 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.32873553 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22730567 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.05573841 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.03341588 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94930682 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.60156113 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.52481156 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.47635730 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.47145343 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.46477584 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.43552205 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.28030743 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.27013145 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11192216 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.09419488 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99430142 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93369475 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.90572487 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.88940323 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.86994601 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85797067 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.77580351 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72588940 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.71365836 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67805277 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64800023 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60697323 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56293290 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53099309 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52186530 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51374162 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.49826343 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46213779 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42349097 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.41674501 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41582170 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37923620 |
| 40 | Thyroid cancer_Homo sapiens_hsa05216 | 1.28775565 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27971478 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20850816 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20011600 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19522318 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19434643 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18719056 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16894923 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16631628 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14852626 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12517045 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12050752 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11147039 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07957951 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07143305 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06529291 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06016414 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02588781 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96074672 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.95609166 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94880228 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94832373 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93728682 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.92236040 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90803619 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89755601 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89406577 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86639357 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 0.85561585 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84616014 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83338726 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81984876 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81389933 |
| 73 | Mismatch repair_Homo sapiens_hsa03430 | 0.81136501 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78958039 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78050850 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76152426 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75128010 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73252978 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72959520 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.72584958 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70994318 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70222615 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69523624 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69253304 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68798587 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.66421072 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64691384 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64381398 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64025201 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63291602 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61880604 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60806467 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60284696 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.60263554 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.60233266 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59826171 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56169859 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55817906 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54401638 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54377361 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53701010 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.52082195 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51911244 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51611260 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50626743 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49255011 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49082909 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.47982461 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47564613 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46758286 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.46483325 |
| 112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46441146 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45275129 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44846453 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.44571314 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.41695791 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41549311 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41334800 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40303591 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39672984 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39020941 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38605376 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.38328856 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36217183 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.35693275 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.35294076 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34582167 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34483704 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.33842552 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33642356 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33622198 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33136129 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31896957 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30945377 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.30752801 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25878809 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25461286 |
| 138 | Ribosome_Homo sapiens_hsa03010 | 0.22406456 |
| 139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.22402303 |
| 140 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16714523 |
| 141 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16473359 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15937697 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.14706702 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14444110 |
| 145 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.14413946 |
| 146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12677368 |
| 147 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09333274 |
| 148 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08872806 |
| 149 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08572055 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04144669 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.03913225 |
| 152 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.03363730 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.00563163 |
| 154 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0164478 |
| 155 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0001830 |

